Search

Your search keyword '"Azevedo, Valderilio F."' showing total 131 results

Search Constraints

Start Over You searched for: Author "Azevedo, Valderilio F." Remove constraint Author: "Azevedo, Valderilio F."
131 results on '"Azevedo, Valderilio F."'

Search Results

5. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases

13. Quality of life in spondyloarthritis: analysis of a large Brazilian cohort

15. Evaluation of performance of BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) in a Brazilian cohort of 1492 patients with spondyloarthritis: data from the Brazilian Registry of Spondyloarthritides (RBE)

17. Epidemiologic profile of juvenile-onset compared to adult-onset spondyloarthritis in a large Brazilian cohort

18. Profile of the use of disease modifying drugs in the Brazilian Registry of Spondyloarthritides

19. Enteropathic arthritis in Brazil: data from the Brazilian registry of spondyloarthritis

23. Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials

24. Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib

28. AB0454 FREQUENCY AND DURATION OF EARLY NON-SERIOUS ADVERSE EVENTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB 5 MG TWICE DAILY AS MONOTHERAPY AND COMBINATION THERAPY

30. AB0768 BASELINE PAIN SEVERITY AS A PREDICTOR OF PAIN IMPROVEMENT FOLLOWING TREATMENT WITH TOFACITINIB IN PSORIATIC ARTHRITIS

31. AB0449 PAIN REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB MONOTHERAPY WITH OR WITHOUT PAIN MEDICATION: A POST HOC ANALYSIS OF POOLED DATA FROM PHASE 2, PHASE 3 AND PHASE 3B/4 STUDIES

35. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

36. TNF-α–induced protein 3 (TNFAIP3) /A20 acts as a master switch in TNF-α blockade–driven IL-17A expression

37. Proceedings of the GRAPPA 2016 Retreat

38. Erratum of “Enteropathic arthritis in Brazil: data from the Brazilian registry of spondyloarthritis”

39. Epidemiologic profile of juvenile-onset compared to adult-onset spondyloarthritis in a large Brazilian cohort

42. Errata de “Perfil epidemiológico da espondiloartrite de início juvenil comparada com a espondiloartrite de início na vida adulta em uma grande coorte brasileira”

43. Erratum on “Epidemiologic profile of juvenile-onset compared to adult-onset spondyloarthritis in a large Brazilian cohort”

44. Perfil epidemiológico da espondiloartrite de início juvenil comparada com a espondiloartrite de início na vida adulta em uma grande coorte brasileira

45. Etanercept biosimilars

46. The Experience with Biosimilars of Infliximab in Rheumatic Diseases

49. Effect of pegylated phosphatidylserinecontaining liposomes in experimental chronic arthritis.

50. An analysis of 372 patients with anterior uveitis in a large Ibero-American cohort of spondyloarthritis: the RESPONDIA Group.

Catalog

Books, media, physical & digital resources